Genstruct

Genstruct was a systems biology company that specialized in causal network modeling to accelerate drug discovery and development. The company utilized its proprietary Molecular Epistemology platform to integrate high-throughput data into mechanistic models of disease biology. These models helped pharmaceutical partners identify biomarkers, predict drug response, and understand mechanisms of toxicity. In 2010, Genstruct rebranded as Selventa to shift its focus toward personalized medicine and the development of diagnostic tests. The company was a key player in the early bioinformatics and systems biology space, collaborating with major firms like Pfizer and GSK.